RMD · 8-K · 20260806PR337962

Operating Cash Flow Trends

RESMED INC · 2026-08-06 · Importance 52 · Surprise 30

Fiscal-year operating cash flow increased 3% to $1,805.8 million from $1,751.6 million, while free cash flow declined 1% to $1,650.0 million from $1,661.7 million. Fourth-quarter operating cash flow declined 16% to $454.6 million, and free cash flow declined 21% to $404.0 million. Fiscal-year free cash flow was calculated after $156.3 million of property, plant, and equipment purchases. Fourth-quarter cash generation supported $287 million of shareholder returns while ResMed continued investment in innovation and growth initiatives.

Key facts

• FY 2026 operating cash flow: $1.8 billion source
• FY 2026 free cash flow: $1.6 billion source
• Q4 operating cash flow totaled $455 million and Q4 free cash flow totaled $404 million source
• Three months ended June 30, 2026 operating cash flow (net cash provided by operating activities): $454,631 thousand; three months ended June 30, 2025: $538,766 thousand source
• Free cash flow is defined as operating cash flow less purchases of property, plant and equipment source